Application for Further Review of Protest Number 0401-08-100154 Eligibility for Glucose Test Strip Layers for Duty Free Treatment as Articles for the Handicapped under Subheading 9817.00.96 of the Harmonized Tariff Schedule of the United States (HTSUS)
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The PET substrate film layers for the NOVA glucose monitor test strips described above are specially designed or adapted for the use or benefit of the physically handicapped, and therefore, eligible for duty-free treatment under subheading 9817.00.96, HTSUS.
Ruling text
This is our decision regarding the Application for Further Review of Protest number 0401-08-100154, timely filed on behalf of Nova Biomedical Corporation by the law firm of Middleton & Shrull regarding the eligibility of various test strip layers for glucose test meters for duty-free treatment as articles specially designed or adapted for the use or benefit of handicapped persons under subheading 9817.00.96, HTSUS. Samples of the products at issue were submitted for our consideration.
FACTS: The focus of Protestant’s business, Nova Biomedical Corporation (Nova), is hospital blood testing analyzers, chemistry analyzers for biotechnology, self testing diabetes products, and medical device development and manufacturing. Some of its focus includes developing technology and products for fast whole blood analyzers to support the care of critically ill patients.
The products that are the subject of this protest are parts designed for producing test strips used in testing the glucose (sugar) level in whole blood. The test strips are a part of the Nova’s blood glucose monitor. The glucose monitor measures a patient’s glucose level in his capillary whole blood. The way the glucose monitor works is that the test strips are inserted into the glucose test monitor.
The patient lances a finger and draws a small amount of blood sufficient to fill the wells on the test strip, and the test monitor instantaneously reads the blood sample and provides the reading on the monitor screen. There are two types of test strips. One type of test strip is composed of four layers and the other type of test strip is composed of five layers. Nova holds a patent for the manufacture of the finished test strips.
The five layer test strips are employed in the glucose testing monitors that hospitals use. The first layer of material is manufactured in the United States, while the remaining four layers used in making the test strips are imported. The final processing of the test strips involves combining all of the different layers into the finished test strips, which is performed in the United States. Since the first layer is made in the United States, we do not need to consider it.
The second layer of the test strips is a single sided medical grade adhesive film. The layer is composed of a polyethylene terephthalate (PET) film substrate. The white film undergoes a corona treatment which improves the “wettability” and the adhesion characteristics of the substrate. The “wettability” of the material is a critical characteristic not only because of its use in processing the blood sample, but also in accepting the specially blended medical adhesive material.
The product is imported in 6 x 10 inch sized sheets. Each of these sheets contains 200 prefabricated perforated and aligned test strips. Four circular holes will line up to create the “wells” (where the chemistry to test the blood samples are deposited), and the vent-hole rectangles adjacent to each 4 hole group. The third layer of the test strips also consists of a PET film substrate that has also undergone corona treatment.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (H039775).